AD/PD - Advances in Science & Therapy’s Post

✋Raise your hand if you have completed the HOD Patient Registry yet! We are so close to hitting our goal of 50 full participants. We only need 16 more!! Will you be our #HODHero today? 🌈The more you know: Our data shows that 82.4% of participants report that they have some level of Nystagmus and 88.2% of participants report that they have some level of ataxia. Wow! That is eye opening! 👀 Speaking of eyes, 67.6% of participants report experiencing some level of double vision. This one surprised us! We thought that everyone had double vision! 🎉Come on! It’s time for you to join the party. Participate in the registry today. You can join here: https://lnkd.in/gxAhwHym ⭐Want to learn more before you commit? You can watch our previous webinars about CoRDS on our YouTube channel. Why not subscribe today? https://lnkd.in/geDPsH3Y #HypertrophicOlivaryDegeneration #HOD #HODHeroes #HODAwareness #MakingHODHistory #NeuroScience #PatientRegistry

Researchers at the George Washington University School of Medicine and Health Sciences (GWSMHS) discovered that a protein called Snail plays a key role in coordinating the response of brain cells after an injury. Learn more about this fascinating study published in PNAS Nexus: https://lnkd.in/eSF6jD7d #GWSMHS #MedEd #BrainHealth #MedicalResearch #Neuroscience #Health #GWResearch

The George Washington University School of Medicine and Health Sciences researchers discover snail 🐌 Not that kind... The protein called Snail may play a role in healing brain injury. This could lead to better treatment for stroke and other brain injuries 🧠 "Our findings reveal the intricate ways the brain responds to injuries,” said senior author Robert Miller, PhD, the Vivian Gill Distinguished Research Professor and vice dean of the GW SMHS. ”Snail appears to be a key player in coordinating these responses, opening up promising possibilities for treatments that can minimize damage and enhance recovery from neurological injuries." Thanks Leigh A. Frame, PhD, MHS for sharing! #stroke #researchandnews #braininjury

The world-first direct to consumer brain scan, now available in the UK, hopes to play a key role in the fight against neurodegenerative diseases and invisible brain injuries. Find out how we got on when we tested the technology. MYndspan #dementia #neuroscience https://lnkd.in/gCHvmmmr

Great to be featured in NR Times, highlighting how MYndspan is transforming brain health accessibility. “I have seen firsthand the potential of this technology to help those suffering from brain health issues.” - Dr Emer MacSweeney Brain health = better prevention, earlier diagnoses, and timely interventions. 💡 Read the full article ⬇️

This #ParkinsonsAwarenessMonth, discover which conditions, often linked to chronic inflammation, can elevate the risk of #Parkinsons. In this Q&A, world-leading researcher, Dr. Michael Schlossmacher, touches on these factors and the promising (but not yet mainstream) discoveries that could change how we treat the disease. https://bit.ly/3UcN9eR #ParkinsonsAwareness #ParkinsonsAwarenessMonth #Neuroscience #PD #ParkinsonsDisease #Ottawa #ParkinsonsResearch

During Alzheimer’s Disease Awareness Month, we recognize the urgent need for innovative approaches to Alzheimer’s research. With the population aging, it’s estimated that cases of Alzheimer’s could triple by 2050. At Pharmaron, we proudly support scientific advancements to improve our understanding of this disease and drive new therapeutic possibilities. By empowering our partners with the resources and expertise needed to move from research to real-world impact, we are working together to create a future where Alzheimer’s care and prevention are more vital than ever. Explore how Pharmaron supports advancements in neuroscience: https://lnkd.in/dvCVPZ9V #AlzheimersDisease #AlzheimersAwareness #Pharmaron #HealthInnovation #Neuroscience #LifeSciences

Mount Sinai researchers have uncovered how neurotransmitters like serotonin, dopamine, and histamine regulate brain function by modifying DNA. This discovery could lead to new therapies for circadian rhythm disruptions, insomnia, depression, and neurodegenerative diseases. Learn more: https://mshs.co/4gYDnY6 #Neuroscience #Research #CircadianRhythms #BrainHealth #Innovation

New blog from Dr Connor Richardson providing an overview of the latest strides in understanding cognitive reserve, resilience, and their role in combating dementia. Connor shares his reflections from the recent Alzheimer's Association® Reserve, Resilience, and Protective Factors PIA year in Review - the discussion spans seminal papers and explores mechanisms like Brain Maintenance and Brain Reserve, which are essential in maintaining cognitive function with age and disease. Key takeaways include the significant impact of educational attainment on dementia resistance and the intriguing role of astrocytes in preclinical Alzheimer's disease scenarios. Such insights not only deepen our understanding but also pave the way for targeted interventions. Stay tuned for more breakthroughs as we continue to unravel the complexities of the brain and its resilience against cognitive decline. 🔗 Connect and engage to explore how these findings can influence future research and healthcare strategies. #DementiaResearch #CognitiveResilience #Neuroscience #HealthcareInnovation https://lnkd.in/eqQFpJ5a

In our next webinar with the title “From Light to Insight: fNIRS in Parkinson’s Research”, Dr. Edgar Guevara will explain how fNIRS can be used to study patients with Parkinson’s disease, giving an overview of current research findings and future perspectives. 🟡 The webinar is free of charge 🟡 It will be held on 17th of July 2024 at 8:00 AM CST / 4:00 PM CEST time 🟡 A link and invitation will be provided after registering More info and registration 🔗 https://lnkd.in/gbfacz4n #webinar #neuroscience #fnirs #parkinsonsresearch